<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-32016" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Radiation Therapy for Heterotopic Ossification Prophylaxis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Anna</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Maani</surname>
            <given-names>Elizabeth V.</given-names>
          </name>
          <aff>UT Health San Antonio / South Texas VA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Amin</surname>
            <given-names>Neha P.</given-names>
          </name>
          <aff>University of Maryland School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anna Lee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Elizabeth Maani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Neha Amin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-32016.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Heterotopic ossification is mature, and lamellar bone formation is in soft tissues where bone does not normally exist. It is commonly seen following trauma or surgical intervention of periarticular soft tissue and is commonly associated with injury to the hip. The&#x000a0;3 primary causes can be grouped into traumatic, neurogenic, and genetic etiologies. Heterotopic ossification from trauma can occur following fractures, dislocations, and operative procedures such as open reduction-internal fixation or total hip arthroplasties. The most commonly involved compartment of the hip is the abductor compartment. The elbow is the next most commonly involved joint, and heterotopic ossification often occurs following burns or elbow replacements. This activity describes the causes, pathophysiology, and presentation of heterotopic ossification and highlights the role of the inter-professional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the causes of heterotopic ossification.</p></list-item><list-item><p>Determine&#x000a0;the presentation of a patient with heterotopic ossification.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment options for heterotopic ossification.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving coordination amongst the inter-professional team to enhance care for patients affected by heterotopic ossification.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32016">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-32016.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Heterotopic ossification (HO) is the formation of mature lamellar bone in soft tissues where bone does not normally exist. HO is commonly seen following trauma or surgical intervention in periarticular soft tissue and is commonly associated with hip injury. The&#x000a0;3 primary causes can be grouped into traumatic, neurogenic, and genetic etiologies.</p>
        <p>HO from trauma includes fractures, dislocations, and operative procedures such as open reduction-internal fixation (ORIF) or total hip arthroplasties (THA). The hip's most involved compartment is the abductor compartment.<xref ref-type="bibr" rid="article-32016.r1">[1]</xref>&#x000a0;The elbow is the next most commonly involved joint following burns or elbow replacements.</p>
        <p>Neurogenic causes include spinal trauma and head injuries and again occur around major joints. The relationship between neurohumoral factors and the development of HO is poorly understood but is centered around the stimulation of osteoblasts to lay down ectopic bone.<xref ref-type="bibr" rid="article-32016.r2">[2]</xref></p>
        <p>The last main etiology includes genetic disorders, such as fibrodysplasia ossificans progressiva, progressive osseous heteroplasia, and Albright hereditary osteodystrophy. These rare conditions lead to the development of HO early in life, resulting in debilitating morbidity.<xref ref-type="bibr" rid="article-32016.r3">[3]</xref></p>
      </sec>
      <sec id="article-32016.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The sensitivity of osteogenic progenitors to radiation therapy was known starting in the 1950s during experiments with bone repair.<xref ref-type="bibr" rid="article-32016.r4">[4]</xref>&#x000a0;These early studies harnessed the HO process; primitive mesenchymal cells in the surrounding soft tissues are transformed into osteoblastic tissue. This tissue then forms mature lamellar bone from dysfunctional bone formation/remodeling. It is&#x000a0;thought that Craven et al found osteogenic progenitor cells&#x000a0;to be radiosensitive because of a high mitotic rate as they&#x000a0;proliferate and differentiate into osteoblasts and chondrocytes.<xref ref-type="bibr" rid="article-32016.r5">[5]</xref>&#x000a0;Thus, low-dose radiation is used as a prophylactic treatment to decrease the chance of HO formation, as discussed below.</p>
      </sec>
      <sec id="article-32016.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of heterotrophic ossification is more than 50% and as high as 90% in patients with moderate or severe osteophytes at the femoral head and socket in the setting of a hip replacement.<xref ref-type="bibr" rid="article-32016.r6">[6]</xref><xref ref-type="bibr" rid="article-32016.r7">[7]</xref>&#x000a0;The hip is the most common site, followed by the elbow. Other major joints are sometimes affected. Soft tissue locations that are not associated with joints are rarely involved.</p>
        <p>Several risk factors have been identified. High-risk patients include those with bilateral hypertrophic osteoarthritis, a prior history of HO, and arthritis caused by trauma characterized by hypertrophic osteophytosis.<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12470043/">[8]</ext-link> Moderate-risk&#x000a0;patients include those with unilateral hypertrophic osteoarthritis, ankylosing spondylitis, Paget disease, or diffuse idiopathic skeletal hyperostosis (DISH). Furthermore, HO is twice as common in males compared to females over 65 at the time of surgery&#x000a0;and lateral surgical approach of the hip.<xref ref-type="bibr" rid="article-32016.r8">[8]</xref><xref ref-type="bibr" rid="article-32016.r9">[9]</xref></p>
      </sec>
      <sec id="article-32016.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most commonly, patients present with hip stiffness after surgery or trauma that can lead to decreased range of motion and functional impairment. Symptoms associated with severe HO may&#x000a0;include fever, warmth, erythema, tenderness, and swelling. Pain alone within several days after surgery could be a presenting symptom of HO, but this presentation is less common.</p>
        <p>HO could also be an incidental radiograph finding, where calcified structures with blurred contours are seen as early as&#x000a0;2 to&#x000a0;6 weeks postoperatively. Bone scans usually show&#x000a0;increased uptake in the soft tissues adjacent to the hip. Scans&#x000a0;can detect HO several days before it becomes apparent on plain film, but these findings are not specific to HO.<xref ref-type="bibr" rid="article-32016.r10">[10]</xref>&#x000a0;Maturation of the HO may take up to&#x000a0;1 or&#x000a0;2 years. Rarely have correlations been reported with a sedimentation rate greater than 35 mm/hr&#x000a0;and a serum alkaline phosphatase greater than 250 international units/L in cases with severe HO.<xref ref-type="bibr" rid="article-32016.r11">[11]</xref><xref ref-type="bibr" rid="article-32016.r12">[12]</xref></p>
      </sec>
      <sec id="article-32016.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>HO is typically evaluated radiographically. The Brooker Staging system is the most widely accepted classification system and includes&#x000a0;4 grades based on an anteroposterior (AP) radiograph of the pelvis and hip.<xref ref-type="bibr" rid="article-32016.r13">[13]</xref>&#x000a0;Grades 3 and 4&#x000a0;are clinically relevant, without pain or impaired mobility.</p>
        <p>
<bold>Brooker Staging System</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Grade 1: Bone islands in the soft tissue around the hip</p>
          </list-item>
          <list-item>
            <p>Grade 2: Exophytes in the pelvis or proximal end of the femur with at least 1 cm between opposing bone surfaces</p>
          </list-item>
          <list-item>
            <p>Grade 3: Exophytes in the pelvis or proximal end of the femur with less than 1 cm between opposing bone surfaces</p>
          </list-item>
          <list-item>
            <p>Grade 4: Bony ankylosis between the proximal femur and pelvis&#x000a0;<xref ref-type="bibr" rid="article-32016.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-32016.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment depends on the severity and symptoms of HO or the patient's risk of developing HO. The orthopedic surgeon often determines the type of HO prophylaxis the patient obtains. Early-grade cases that are asymptomatic may be observed. Advanced HO may require surgical resection followed by prophylactic modalities, such as medical therapy and radiation therapy (RT), to help minimize the high risk for re-development of HO. When a patient does not have a history of HO, the decision to offer prophylactic treatment is often weighed with patient-related, clinical, and surgical risk factors against the potential risks of preventative treatment.</p>
        <p>
<bold>Medical Therapy</bold>
</p>
        <p>The&#x000a0;main&#x000a0;medical therapy used for HO prophylaxis is nonsteroidal anti-inflammatory drugs (NSAIDs). While indomethacin is the most commonly used NSAID, other NSAIDs, such as ibuprofen, have been&#x000a0;effective&#x000a0;with the added benefit of ease of administration and low cost. The recommended dose of indomethacin is 75 to 100 mg/day for 7 to 14 days postoperatively, with care for gastrointestinal side effects such as gastritis and ulcer formation.<xref ref-type="bibr" rid="article-32016.r14">[14]</xref></p>
      </sec>
      <sec id="article-32016.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for radiation therapy for heterotopic ossification prophylaxis<bold>&#x000a0;</bold>include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Fracture</p>
          </list-item>
          <list-item>
            <p>Hematoma</p>
          </list-item>
          <list-item>
            <p>Local trauma</p>
          </list-item>
          <list-item>
            <p>Septic arthritis</p>
          </list-item>
          <list-item>
            <p>Thrombophlebitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-32016.s9" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>Radiation therapy is more effective than NSAIDs in multiple trials. The effectiveness of indomethacin versus radiation therapy for HO prevention was compared in a prospective randomized trial comparing post-open reduction/internal fixation surgery for patients with an acetabular fracture. RT was given as 8 Gy in 1 fraction within 72 hours of surgery, and indomethacin was given for&#x000a0;6 weeks. There was a greater risk of nonunion of long bone fractures among those who received indomethacin over RT (26% versus 7%, p = 0.004).<xref ref-type="bibr" rid="article-32016.r15">[15]</xref>&#x000a0;A subsequent meta-analysis by Pakos et al analyzed&#x000a0;7 randomized trials for 1,143 patients and found that RT was almost twice as effective as NSAIDs. Still, the absolute benefit was less than 2%, with efficacy being dose-dependent.<xref ref-type="bibr" rid="article-32016.r16">[16]</xref></p>
        <p>
<bold>Radiation Dosing and Fractionation</bold>
</p>
        <p>External beam radiation therapy for HO prophylaxis is often prescribed at a 7 to 8 Gy single fraction dose. Still, various studies have shown that several fractionation and dosing regimens are acceptable. Historically, 20 Gy in 10 fractions was administered based on pediatric observational studies of bony growth inhibition. Sylvester et al retrospectively compared this regimen to 10 Gy in 5 fractions in 27 hips after THA and found the&#x000a0;2 groups similarly effective.<xref ref-type="bibr" rid="article-32016.r17">[17]</xref>&#x000a0;Around this time, Lo et al retrospectively examined outcomes after a single fraction RT with a 7 Gy dose and found that none of the patients developed grade 3 or 4 HO.<xref ref-type="bibr" rid="article-32016.r18">[18]</xref>&#x000a0;Another single fraction regimen with 8 Gy was compared in a randomized trial with 10 Gy in 5 fractions in 62 hips. With a median follow-up of&#x000a0;6 months, the failure rate in both groups was equivalent to 21%.<xref ref-type="bibr" rid="article-32016.r19">[19]</xref>&#x000a0;As the single fraction was shown to be effective, Healy et al explored the efficacy of lowering the dose. In this retrospective analysis, 107 hips were given either 7 Gy or 5.5 Gy postoperatively. The radiographic failure rate was 10% versus 63% in the lower-dose arm, which was significantly different.<xref ref-type="bibr" rid="article-32016.r20">[20]</xref>&#x000a0;A recent study compared lower doses in a randomized prospective trial in 59 high-risk patients for HO. The&#x000a0;2 arms were 5 Gy in 2 fractions or 10 Gy in 5 fractions, and all patients were treated within&#x000a0;4 days of surgery. There was a trend toward increased HO of any grade in the 5 Gy arm (69% versus 43%, p = 0.09).<xref ref-type="bibr" rid="article-32016.r21">[21]</xref></p>
        <p>
<bold>Radiation Timing</bold>
</p>
        <p>RT is typically given either preoperatively within 24 hours or postoperatively within 72 hours. If surgery is planned, it is ideal that the patient be consulted and consented to before surgery since the anesthesia may render the patient unable to give informed consent. Also, the patient could be in more pain postoperatively and may not be able to lie still during treatment. However, in trauma or emergencies, the radiation would be given postoperatively.</p>
        <p>A randomized, multi-institutional trial by Gregoritch et al compared patients treated with pre-op versus post-op 7-8 Gy in 1 fraction and found that the radiographic and clinical failure rates between the&#x000a0;2 groups were not significantly different.<xref ref-type="bibr" rid="article-32016.r22">[22]</xref>&#x000a0;This was examined in another randomized study of 161 patients treated preoperatively less than&#x000a0;4 hours before surgery or postoperatively less than 72 hours after surgery. There was no significant difference amongst patients with Brooker grades 0 to 2; however, treatment failures in the overall cohort were significantly lower in the postoperative group. This was likely due to a higher biological equivalent dose as the preoperative group received 7 Gy in 1 fraction, while the postoperative group received 17.5 Gy in 5 fractions. Despite these findings, the current standard is to use the same dose of single fraction 7 to 8 Gy within 24 hours pre-operatively or within 72 hours postoperatively.</p>
        <p>
<bold>Radiation Treatment Planning</bold>
</p>
        <p>The general principle of treatment planning should include standard techniques with immobilization devices if necessary and placement of the patient in a comfortable position that allows reproducibility for daily treatments. The target volumes should include the surfaces of the bone that are most often involved with HO or the periarticular HO. HO often forms between the femoral head and pelvis, either from the greater trochanter to the ilium or the lesser trochanter to the ischium, so these surfaces must be included in the radiation field.</p>
        <p>The radiation techniques to treat a hip with HO have been well described for the hip as this is the most commonly treated site. The patient is treated supine in a comfortable and reproducible position. Each field is customized to the patient&#x02019;s anatomy. Still, generally, the cranial border is about 3 cm above the acetabulum, the inferior border&#x000a0;about 3 cm below the lesser trochanter of the femoral head, or could include the upper 1/3 of the implant shaft (if used) with a field size of about 14 x 10 cm. Soft tissue can be blocked by collimating the field to use the field edges or using the multi-leaf collimators to shape the field to allow about a 1.5 to 2 cm margin on the bone and prior areas of HO. Three-dimensional conformal radiotherapy (3DCRT) using anterior-posterior/posterior-anterior (AP/PA) fields with 6 to 15MV photons are often used to create a homogeneous plan to cover the target to at least the 95% isodose line while minimizing dose to the surrounding soft tissue and skin (See <bold>Image.</bold>&#x000a0;Heterotopic&#x000a0;Ossification of the&#x000a0;Hip).</p>
        <p>
<bold>Other Sites</bold>
</p>
        <p>The hip is the most common site of HO development and treatment. However, other joints are also susceptible to HO. RT has also been effective in these areas, particularly with the elbow. A study of 36 patients treated at the Cleveland Clinic with 7 Gy in 1 fraction following elbow surgery found that RT was associated with favorable functional and radiographic outcomes.<xref ref-type="bibr" rid="article-32016.r23">[23]</xref>&#x000a0;Furthermore, a retrospective study by Strauss et al of 44 patients found radiographic evidence of HO in 48% of the group with no complications after high-risk elbow surgery.<xref ref-type="bibr" rid="article-32016.r24">[24]</xref>&#x000a0;Favorable outcomes were reported from a case series of&#x000a0;9 patients with clinically significant HO at the elbow. Fractionation included 5 Gy in 2 fractions and 6-7 Gy in 1 fraction with a median follow-up of 7.7 months; there were no failures, with the majority showing clinical improvement.<xref ref-type="bibr" rid="article-32016.r25">[25]</xref></p>
        <p>
<bold>Toxicity from Radiation</bold>
</p>
        <p>HO is not a malignant condition, yet it can cause pain and limited mobility and negatively affect the quality of life. Thus, the benefits of treatment must be weighed against the risks. Patients are often counseled that the low RT dose administered for HO prophylaxis decreases the risk of HO significantly with minimal side effects and is considered a safe treatment overall. Potential side effects are rare but include fatigue, wound healing delays, joint swelling, and an extremely low chance of secondary cancer from the RT.</p>
        <p>Secondary malignancies from radiation can develop in the bone or tissues included in a previous RT field. Since the total dose given for HO prophylaxis is very low, the changes of secondary malignancies are also extremely low, but not zero. At least&#x000a0;2 case reports have described secondary malignancies after a single fraction. The first case described a 51-year-old patient who received 7 Gy x 1 for HO 15 years earlier. He underwent a second course of 7 Gy x 1 for debilitating HO but developed high-grade undifferentiated sarcoma of the proximal thigh 16 months after his second treatment.<xref ref-type="bibr" rid="article-32016.r26">[26]</xref>&#x000a0;Another case described a 26-year-old male who underwent surgery for an acetabular fraction and received 7 Gy in 1 fraction postoperatively for HO prophylaxis. He presented 11 years later with osteosarcoma of the treated area, which was treated definitively with neoadjuvant cisplatin and adriamycin, with plans for surgical resection at the time of the report.<xref ref-type="bibr" rid="article-32016.r27">[27]</xref>&#x000a0;Otherwise, there are no other reported cases of secondary malignancies from RT given for HO prophylaxis treatment, as it is a rare complication.</p>
        <p>Trochanteric nonunion and wound healing complications are also potential toxicities from RT. One study found that the rate of nonunion ranged from 12% to 30% after RT, while the rate of nonunion was diminished by 2% to 15% of the time for those who did not get RT.<xref ref-type="bibr" rid="article-32016.r3">[3]</xref>&#x000a0;Since modern hardware for total hip arthroplasties is cementless and porous, they may rely on bony ingrowth at the acetabulum or the proximal femur region. There is concern that RT may inhibit the necessary bony ingrowth and lead to prosthesis failure, which has prompted some providers to utilize shielding of the acetabular cup to prevent this complication. However, a clinical study of patients receiving preoperative and postoperative radiation found no evidence of prosthesis failure, even without shielding.<xref ref-type="bibr" rid="article-32016.r28">[28]</xref></p>
        <p>For male patients, the RT dose to the testicles is of concern as it can reduce sperm count, even from doses as low as 20 Gy. Testicular shielding is recommended as it can reduce the dose to the testicles by approximately 50%.</p>
      </sec>
      <sec id="article-32016.s10" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key facts to keep in mind about&#x000a0;radiation therapy for heterotopic ossification prophylaxis are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Heterotopic ossification (HO) is the abnormal formation of bone in soft tissues where bone does not normally exist.</p>
          </list-item>
          <list-item>
            <p>HO is most commonly seen following trauma or surgical intervention in periarticular soft tissue and is commonly associated with injury to the hip.</p>
          </list-item>
          <list-item>
            <p>Radiation to the peri-articular joint prescribed to 7 to 8 Gy in 1 fraction given less than 24 hours preoperatively or less than 72 hours postoperatively can decrease the risk of HO development.</p>
          </list-item>
          <list-item>
            <p>Prophylactic RT for HO is safe and is more efficacious compared to NSAIDs.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-32016.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>HO is best managed by an interprofessional team. Today, radiation is being recommended in select patients, and while effective, one has to weigh the benefits versus harm of this therapy in asymptomatic patients. The patient should be involved in decision-making because RT is not entirely harmless.</p>
      </sec>
      <sec id="article-32016.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=32016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=32016">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/radiation-therapy-for-heterotopic-ossification-prophylaxis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=32016">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/32016/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=32016">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-32016.s13">
        <fig id="article-32016.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Heterotopic Ossification of the Hip. Digitally reconstructed radiographs (DRR) based on original portal images showing fields of three patients receiving radiation for heterotopic ossification of the hip. The blue line represents the field edge in the first two images. Take note that the surfaces of the greater trochanter to the ilium and the lesser trochanter to the ischium are not blocked out since this is the most common location for HO formation. The third image shows the shielding of the acetabular cup to prevent bony ingrowth and prosthesis failure. Contributed by NP Amin</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="StatPearlsImage" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-32016.s14">
        <title>References</title>
        <ref id="article-32016.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garland</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>A clinical perspective on common forms of acquired heterotopic ossification.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1991</year>
            <month>Feb</month>
            <issue>263</issue>
            <fpage>13</fpage>
            <page-range>13-29</page-range>
            <pub-id pub-id-type="pmid">1899635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sullivan</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Heterotopic ossification after central nervous system trauma: A current review.</article-title>
            <source>Bone Joint Res</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>51</fpage>
            <page-range>51-7</page-range>
            <pub-id pub-id-type="pmid">23610702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balboni</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Gobezie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mamon</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2006</year>
            <month>Aug</month>
            <day>01</day>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>1289</fpage>
            <page-range>1289-99</page-range>
            <pub-id pub-id-type="pmid">16863921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>COOLEY</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>GOSS</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The effects of transplantation and x-irradiation on the repair of fractured bones.</article-title>
            <source>Am J Anat</source>
            <year>1958</year>
            <month>Mar</month>
            <volume>102</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-81</page-range>
            <pub-id pub-id-type="pmid">13571154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Craven</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Urist</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis by radioisotope labelled cell populations in implants of bone matrix under the influence of ionizing radiation.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1971</year>
            <month>May</month>
            <volume>76</volume>
            <fpage>231</fpage>
            <page-range>231-43</page-range>
            <pub-id pub-id-type="pmid">4931060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeLee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Charnley</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ectopic bone formation following low friction arthroplasty of the hip.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1976</year>
            <season>Nov-Dec</season>
            <issue>121</issue>
            <fpage>53</fpage>
            <page-range>53-9</page-range>
            <pub-id pub-id-type="pmid">825341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritter</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vaughan</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1977</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>345</fpage>
            <page-range>345-51</page-range>
            <pub-id pub-id-type="pmid">403193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahrengart</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lindgren</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Heterotopic bone after hip arthroplasty. Defining the patient at risk.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1993</year>
            <month>Aug</month>
            <issue>293</issue>
            <fpage>153</fpage>
            <page-range>153-9</page-range>
            <pub-id pub-id-type="pmid">8339476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horwitz</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Rockowitz</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Goll</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Balderston</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Rothman</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>A prospective randomized comparison of two surgical approaches to total hip arthroplasty.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1993</year>
            <month>Jun</month>
            <issue>291</issue>
            <fpage>154</fpage>
            <page-range>154-63</page-range>
            <pub-id pub-id-type="pmid">8504594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orzel</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rudd</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Heterotopic bone formation: clinical, laboratory, and imaging correlation.</article-title>
            <source>J Nucl Med</source>
            <year>1985</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-32</page-range>
            <pub-id pub-id-type="pmid">3918147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kjaersgaard-Andersen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Kristensen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1989</year>
            <month>Nov</month>
            <issue>248</issue>
            <fpage>189</fpage>
            <page-range>189-94</page-range>
            <pub-id pub-id-type="pmid">2509120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kjaersgaard-Andersen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kristensen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>NW</given-names>
              </name>
            </person-group>
            <article-title>Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1988</year>
            <month>Sep</month>
            <issue>234</issue>
            <fpage>102</fpage>
            <page-range>102-9</page-range>
            <pub-id pub-id-type="pmid">3136963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooker</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Bowerman</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Riley</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Ectopic ossification following total hip replacement. Incidence and a method of classification.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1973</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>8</issue>
            <fpage>1629</fpage>
            <page-range>1629-32</page-range>
            <pub-id pub-id-type="pmid">4217797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fransen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>MacMahon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Norton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Woodward</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Tregonning</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Windolf</surname>
                <given-names>M</given-names>
              </name>
              <collab>HIPAID Collaborative Group</collab>
            </person-group>
            <article-title>Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial.</article-title>
            <source>BMJ</source>
            <year>2006</year>
            <month>Sep</month>
            <day>09</day>
            <volume>333</volume>
            <issue>7567</issue>
            <fpage>519</fpage>
            <pub-id pub-id-type="pmid">16885182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burd</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Anglen</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion.</article-title>
            <source>J Bone Joint Surg Br</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>85</volume>
            <issue>5</issue>
            <fpage>700</fpage>
            <page-range>700-5</page-range>
            <pub-id pub-id-type="pmid">12892193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pakos</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Ioannidis</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2004</year>
            <month>Nov</month>
            <day>01</day>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>888</fpage>
            <page-range>888-95</page-range>
            <pub-id pub-id-type="pmid">15465207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sylvester</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Selch</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Amstutz</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The use of postoperative irradiation for the prevention of heterotopic bone formation after total hip replacement.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>471</fpage>
            <page-range>471-6</page-range>
            <pub-id pub-id-type="pmid">3343154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Healy</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Covall</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Dotter</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Pfeifer</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Torgerson</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Wasilewski</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation.</article-title>
            <source>Radiology</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>168</volume>
            <issue>3</issue>
            <fpage>851</fpage>
            <page-range>851-4</page-range>
            <pub-id pub-id-type="pmid">3136510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pellegrini</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Konski</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Gastel</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Evarts</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>186</fpage>
            <page-range>186-200</page-range>
            <pub-id pub-id-type="pmid">1541613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Healy</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>DeSimone</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Rask</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pfeifer</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1995</year>
            <month>Apr</month>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>590</fpage>
            <page-range>590-5</page-range>
            <pub-id pub-id-type="pmid">7713977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Padgett</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Holley</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Sumner</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Conterato</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Galante</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study.</article-title>
            <source>J Arthroplasty</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>677</fpage>
            <page-range>677-86</page-range>
            <pub-id pub-id-type="pmid">14513439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gregoritch</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chadha</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pelligrini</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kantorowitz</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1994</year>
            <month>Aug</month>
            <day>30</day>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-62</page-range>
            <pub-id pub-id-type="pmid">8083129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Polster</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Lawton</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2010</year>
            <month>Aug</month>
            <day>01</day>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>1493</fpage>
            <page-range>1493-9</page-range>
            <pub-id pub-id-type="pmid">20637977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Wysocki</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery.</article-title>
            <source>Am J Orthop (Belle Mead NJ)</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>40</volume>
            <issue>8</issue>
            <fpage>400</fpage>
            <page-range>400-5</page-range>
            <pub-id pub-id-type="pmid">22016869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heyd</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Strassmann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schopohl</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zamboglou</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Radiation therapy for the prevention of heterotopic ossification at the elbow.</article-title>
            <source>J Bone Joint Surg Br</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>83</volume>
            <issue>3</issue>
            <fpage>332</fpage>
            <page-range>332-4</page-range>
            <pub-id pub-id-type="pmid">11341414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mourad</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Packianathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shourbaji</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vijayakumar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Radiation-induced sarcoma following radiation prophylaxis of heterotopic ossification.</article-title>
            <source>Pract Radiat Oncol</source>
            <year>2012</year>
            <season>Apr-Jun</season>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-4</page-range>
            <pub-id pub-id-type="pmid">24674090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farris</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chowdhry</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Lemke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kilpatrick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lacombe</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification.</article-title>
            <source>Radiat Oncol</source>
            <year>2012</year>
            <month>Aug</month>
            <day>21</day>
            <volume>7</volume>
            <fpage>140</fpage>
            <pub-id pub-id-type="pmid">22908888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-32016.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seegenschmiedt</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Keilholz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martus</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goldmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>W&#x000f6;lfel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Henning</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sauer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>1997</year>
            <month>Aug</month>
            <day>01</day>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>161</fpage>
            <page-range>161-71</page-range>
            <pub-id pub-id-type="pmid">9300751</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
